INMED PHARMACEUTICALS INC. Inventory, Work in Process, Net of Reserves
INMED PHARMACEUTICALS INC. (INM) had Inventory, Work in Process, Net of Reserves of $0 as of 2025-06-30, per its S-4 filed 2026-07-02.
Financial Statements › Notes › Inventory
us-gaap:InventoryWorkInProcessNetOfReserves · last filed 2026-07-02
- 2025-06-30: Inventory, Work in Process, Net of Reserves $0.00.
- 2024-06-30: Inventory, Work in Process, Net of Reserves $9.61K.
- 2023-06-30: Inventory, Work in Process, Net of Reserves $308.94K.
| Period end | Inventory, Work in Process, Net of Reserves |
|---|---|
| 2025-06-30 | $0.00 S-4 · filed 2026-07-02 |
| 2024-06-30 | $9.61K S-4 · filed 2026-07-02 |
| 2023-06-30 | $308.94K 10-K · filed 2024-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |